Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
Saved in:
| Title: | Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. |
|---|---|
| Authors: | Chang TC; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Matossian MD; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Elliott S; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Burks HE; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Sabol RA; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Ucar DA; Department of Genetics, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America., Wathieu H; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Zabaleta J; Department of Pediatrics, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America., Del Valle L; Department of Pathology, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America., Gill S; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Martin E; Department of Agricultural Engineering, Louisiana State University, Baton Rouge, Louisiana, United States of America., Riker AI; Department of Surgery, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America., Miele L; Department of Genetics, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America., Bunnell BA; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Burow ME; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Collins-Burow BM; Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America. |
| Source: | PloS one [PLoS One] 2020 Oct 09; Vol. 15 (10), pp. e0226464. Date of Electronic Publication: 2020 Oct 09 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0226464 |
